Table 2.
Descriptive sleep data is presented. Subjects in the zolpidem compared to placebo condition spent more time in stage 3 and less time in REM
| Placebo | Zolpidem | |||
|---|---|---|---|---|
| Mean (min) | SD | Mean (min) | SD | |
| TST | 536.48 | 48.12 | 538.37 | 39.67 |
| Stage 1 | 14.16 | 8.52 | 13.625 | 11.69 |
| Stage 2 | 282.804 | 54.36 | 287.78 | 47.33 |
| Stage 3 | 110.82 | 39.83 | 121.21* | 40.78 |
| REM | 128.67* | 32.29 | 115.28 | 28.48 |
| WASO | 31.3 | 27.6 | 25.73 | 26.00 |
| SE | 92.39 | 5.64 | 93.26 | 4.88 |
Table represents mean and standard deviation of each sleep parameter for placebo and zolpidem conditions. Each stage is calculated in minutes. Asterisks represent significance at p < 0.05